Research study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 vaccine mix thumbnail

A small-scale clinical research study of the integrated use of the AstraZeneca and Sputnik Light vaccines versus COVID-19 has revealed strong antibody growth in a majority of the study’s individuals, the Russian Direct Mutual fund stated on Monday.The information was gathered from 20 individuals who participated in a 100- person study in Azerbaijan that started in February. They first received the AstraZeneca shot followed by the one-dose Russian-made Sputnik Light shot 29 days later, RDIF said.” According to the results of the interim analysis, a fourfold or greater boost in neutralising antibodies to the spike protein (S-protein) of the SARS-CoV-2 was found in 85%of the volunteers on the 57 th day of the study,” RDIF said.
Find Out More

By Admin